Literature DB >> 15542454

Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.

Glynn Baker1, Gherardo Mazziotti, Chris von Ruhland, Marian Ludgate.   

Abstract

We aimed to establish and extend the characterization of murine models of thyroiditis and Graves' ophthalmopathy, induced by transfer of TSH receptor (TSHR) primed T cells. Experiments were performed in a different animal unit but using female BALB/cbyJico mice from the same supplier as previously. We report our findings together with a reevaluation of the earlier studies. In the first experiment, genetic immunization or TSHR fusion protein induced TSHR antibodies in all nine mice. Some of the antibodies functioned as thyroid-stimulating antibodies and/or TSH binding inhibiting Igs with two of seven mice having elevated T4. Thyroiditis and orbital changes were absent. Splenocyte transfer induced no immune response in naive BALB/cbyJico recipients. Subsequently genetic immunization or fusion protein-treated mice were maintained in either local or Brussels conditions (water, chow, and bedding). TSHR antibodies were induced in nine of nine Brussels (with decreased T4 in one of nine) but five of nine local mice. No thyroiditis or orbital changes were induced, but misleading fixation artefacts in extraocular muscles were noted. Nonspecific in vitro stimulation induced more CD-4+/IL-4+ cells in Brussels maintained. TSHR stimulation produced a significant increase in IL-4 secretion in six of nine local but one of seven Brussels mice. Thyroids from many TSHR-treated and control mice contained ectopic thymus. Our results confirm that thyroiditis is required for disease transfer but indicate the heterogeneity in TSHR-induced immune response in an inbred strain. Ectopic thymus can masquerade as thyroiditis, and care is required to avoid muscle artefacts. Because neither animal unit is pathogen free, microbial environment may contribute to determining TSHR-induced responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542454     DOI: 10.1210/en.2004-1015

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  News and views: at long last, an animal model of Graves' orbitopathy.

Authors:  Rebecca S Bahn
Journal:  Endocrinology       Date:  2013-09       Impact factor: 4.736

Review 2.  Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment.

Authors:  James A Garrity; Rebecca S Bahn
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

Review 3.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

Review 4.  Total thyroid ablation in Graves' orbitopathy.

Authors:  F Menconi; M Leo; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2015-03-05       Impact factor: 4.256

Review 5.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 6.  Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.

Authors:  Terry J Smith; Laszlo Hegedüs; Raymond S Douglas
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

7.  A drug-like antagonist inhibits thyrotropin receptor-mediated stimulation of cAMP production in Graves' orbital fibroblasts.

Authors:  Susanne Neumann; Arthur Pope; Elizabeth Geras-Raaka; Bruce M Raaka; Rebecca S Bahn; Marvin C Gershengorn
Journal:  Thyroid       Date:  2012-07-11       Impact factor: 6.568

Review 8.  Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy.

Authors:  Andrew G Gianoukakis; Terry J Smith
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-10       Impact factor: 3.243

9.  Thyroid antigens, not central tolerance, control responses to immunization in BALB/c versus C57BL/6 mice.

Authors:  Alexander V Misharin; Basil Rapoport; Sandra M McLachlan
Journal:  Thyroid       Date:  2009-05       Impact factor: 6.568

Review 10.  New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.

Authors:  Peter N Taylor; Lei Zhang; George J Kahaly; Marian Ludgate; Richard W J Lee; Ilaria Muller; Daniel G Ezra; Colin M Dayan
Journal:  Nat Rev Endocrinol       Date:  2019-12-30       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.